The team has discovered that when mice with Type 1 Diabetes are injected with myelin protein — the insulating material that coats neurons — they experience the periods of relapsing and remitting disability associated with brain lesions in humans. And for the first time, they’ve been able to monitor this brain lesion process using magnetic resonance imaging.

Dr. Frenkel believes his finding will lead to the development of more effective treatments for MS.

Read full article and more